A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer
Shanghai Henlius Biotech
Shanghai Henlius Biotech
AstraZeneca
Azienda USL Reggio Emilia - IRCCS
Shandong Cancer Hospital and Institute
Sun Yat-sen University
Beijing Tiantan Hospital
Tianjin Medical University Cancer Institute and Hospital
Peking University
Peking University
AbbVie
Qingdao University
European Lung Cancer Working Party
Tianjin Medical University Cancer Institute and Hospital
GlaxoSmithKline
Pfizer